Full-Time

Care Transition Coordinator

Deadline 6/18/27
BrightSpring Health Services

BrightSpring Health Services

10,001+ employees

Home-based health services and pharmacy solutions

Compensation Overview

$75k - $85k/yr

Morgantown, WV, USA

In Person

Category
Medical, Clinical & Veterinary (1)
Required Skills
Sales
Marketing
Care Coordination
Patient Education

Get referred to BrightSpring Health Services

See people who can refer or advise you

Requirements
  • At least one year of experience in home health or hospital-based case management.
  • Current and active licensure in the state of practice as a Registered Nurse, Licensed Practical Nurse, Social Worker, or Physical Therapist.
  • A valid driver's license, reliable transportation, and current auto insurance.
  • Understanding of home health eligibility criteria and Medicare and insurance coverage guidelines.
Responsibilities
  • Achieve monthly personal production goals and Medicare-certified admission targets for assigned locations, while managing sales and marketing expenses for financial stewardship and return on investment.
  • Implement weekly, monthly, and quarterly strategies to increase market share within assigned facilities.
  • Evaluate patients and physician orders for home care eligibility in accordance with Right of Choice guidelines.
  • Conduct face-to-face patient transitions, provide agency education, and identify the primary care physician responsible for the plan of care.
  • Present identified patient needs to the Executive Director for branch approval and acceptance, and complete Care Transition Coordinator encounter documentation in Home Care Home Base.
  • Coordinate transfer orders and ancillary services, including durable medical equipment and infusion, after patient acceptance.
  • Educate patients on home care or hospice orders and related services received from referral sources.
  • Ensure patient needs identified by referral sources are documented and addressed by the agency upon acceptance.
  • Collaborate with the Executive Director and Clinical Director to align team efforts with referral source and patient needs.
  • Perform sales administration duties, including BOA expense entry, adherence to BOA policies and procedures, payroll timesheet submission, weekly 3LS meetings, PTO requests, required sales calls, and company-provided in-services.
  • Maintain timely communication by phone and email.
  • Educate patients on post-discharge physician appointments, prescriptions needed before discharge, medication regimens, pharmacy use, and delivery methods.
  • Act as liaison between the agency and healthcare providers for newly referred patients and existing patients transferred to hospitals from home health services.
  • Notify discharge planning when active patients transfer from home health to a facility.
  • Coordinate resumption of care with patients before discharge when applicable orders are obtained.
  • Provide follow-up feedback to the case management team on readmission status and non-admit decisions based on agency-provided information.
  • Maintain patient confidentiality in accordance with applicable laws and agency policies.
  • Demonstrate knowledge of agency services, competitive advantages, specialty programs, and Medicare guidelines, and educate medical professionals using appropriate tools and literature.
Desired Qualifications
  • One to three years of experience in medical marketing or healthcare business development.
  • Respiratory Therapist certification and/or completion of a technical clinical program demonstrating strong clinical knowledge.
BrightSpring Health Services

BrightSpring Health Services

View

BrightSpring Health Services delivers home and community-based health services for people with complex or chronic needs, organized into two segments: Pharmacy and Provider. The Pharmacy segment provides specialty, infusion, and community pharmacy services to patients with complex conditions. The Provider segment offers behavioral health, home health, hospice care, and services for individuals with intellectual and developmental disabilities. The company runs an integrated care model through a network of pharmacies and providers to support a continuum of care that includes clinical services, care coordination, and in-home support. Revenue comes from Medicare, Medicaid, and private insurance, reflecting reimbursement across public and private payers. The goal is to coordinate pharmacy and in-home health services to improve access, continuity, and outcomes for patients and to serve managed care organizations with a complete care solution.

Company Size

10,001+

Company Stage

Post IPO Equity

Headquarters

Louisville, Kentucky

Founded

1974

Get referred to BrightSpring Health Services

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q2 2026 revenue rose 23% to $3.87 billion, with EBITDA up 44%.
  • Management raised 2026 EBITDA guidance to $820 million–$845 million on July 31, 2026.
  • Leverage fell to 2.15x, and S&P and Moody’s upgraded BrightSpring’s credit.

What critics are saying

  • IRA pricing cuts reduced Home and Community Pharmacy 8% in Q2 2026.
  • Management expects roughly $200 million 2026 IRA pressure, crushing pharmacy margin leverage.
  • PharMerica’s breach settlement and security spending drain cash during Amedisys integration.

What makes BrightSpring Health Services unique

  • BrightSpring combines specialty pharmacy with home-based provider services across complex chronic care.
  • Its 2026 portfolio reached 153 ultra-narrow drugs, strengthening limited-distribution access advantages.
  • Amedisys and LHC branches deepen BrightSpring’s local density in home health and hospice.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible Work Hours

Growth & Insights and Company News

Headcount

6 month growth

-10%

1 year growth

-10%

2 year growth

-10%
Yahoo Finance
Aug 20th, 2026
BrightSpring Health Services posts 23.9% revenue growth as Solventum and Inspire Medical face headwinds

BrightSpring Health Services stands out as a strong long-term healthcare investment, whilst Solventum and Inspire Medical Systems face headwinds, according to recent analysis. Healthcare stocks have surged 27.5% over the past six months, outperforming the S&P 500 by 16.2 percentage points. However, increased venture capital has intensified competition across the sector. BrightSpring, which provides home health care, hospice, and pharmacy services, has achieved 23.9% annual revenue growth over the past two years. Analysts forecast 14.1% revenue growth for the next 12 months. Conversely, Solventum faces weak demand with flat revenue expected, whilst its free cash flow margin has declined 18.2 percentage points over five years. Inspire Medical Systems confronts a forecasted revenue decline of 3.5% for the upcoming year.

Yahoo Finance
Aug 18th, 2026
Two profitable stocks with solid fundamentals and one to ignore

Two companies leverage profitability to outpace competitors, whilst another faces headwinds, according to StockStory's analysis. Primoris, which builds and maintains infrastructure in utility, energy, and civil construction sectors, struggles with a low gross margin of 10.3% reflecting high production costs. The company has seen falling earnings per share over two years and weak free cash flow margin of 2.2% over five years. BrightSpring Health Services, offering home health care and pharmacy services, has posted 23.9% annual revenue growth over two years. Its revenue base of $14.37 billion provides economies of scale. Pfizer's massive $63.7 billion revenue base gives it significant negotiating power. The pharmaceutical giant's adjusted operating margin expanded by 18.5 percentage points over two years, whilst delivering a 17.5% return on capital.

Yahoo Finance
Aug 9th, 2026
BrightSpring Health Services beats Q2 expectations with 23% revenue growth to $3.87B

BrightSpring Health Services exceeded Wall Street expectations in Q2, delivering revenue of $3.87 billion and adjusted earnings per share of $0.45, beating analyst estimates by 5.9% and 13% respectively. The company's Specialty and Infusion pharmacy business drove growth, with revenue up 30% and script growth of 31% year-over-year. CEO Jon Rousseau attributed the performance to new limited distribution drug launches and broad-based volume growth. However, segments like Home and Community Pharmacy faced challenges from customer exits and regulatory headwinds. The company raised its full-year revenue guidance to $15.26 billion at the midpoint, up 1.9% from previous guidance. Operating margin improved to 3.4%, compared to 1.5% in the prior-year quarter. Despite the strong results, the market reacted negatively, reflecting concerns about underlying business headwinds.

Yahoo Finance
Aug 6th, 2026
Micron leads 3 profitable stocks with strong net income ratios smart investors are buying

Micron Technology, BrightSpring Health Services, and Custom Truck One Source have emerged as standout profitable stocks based on strong net income ratios and growth prospects. The selection criteria included a Zacks Rank of #1, trailing 12-month sales and net income growth exceeding industry averages, and a net income ratio higher than the industry standard. Micron Technology, a global memory and storage provider, shows particularly impressive metrics with a 12-month net profit margin of 55.9%. The company's expected earnings growth rate for the current year stands at 791%. The screening process, using the Zacks Research Wizard, filtered more than 7,685 stocks down to just 13 that met all criteria. The net income ratio helps investors assess a company's ability to cover both operating and non-operating expenses with revenues.

Yahoo Finance
Aug 1st, 2026
BrightSpring Health Services shares drop 17.5% despite strong Q2 results and raised guidance

BrightSpring Health Services shares fell 17.5% after reporting second-quarter results, despite beating expectations. The healthcare services provider posted revenue of $3.87 billion, up 23% year-on-year, whilst non-GAAP profit reached $0.45 per share, exceeding forecasts. The company also raised its full-year guidance. However, investors responded negatively in what appeared to be a "sell-the-news" reaction. The sell-off may stem from valuation concerns and stagnant profit margins despite rising sales, raising questions about the company's cost structure. The stock has experienced 18 movements greater than 5% over the past year. At $59.71 per share, BrightSpring trades 18.1% below its 52-week high of $72.91 from July, though it remains up 55.5% year-to-date.